SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2015 / Cilt: 49 - Sayı: 2

Infantile hemangioma and oral propranolol therapy

İnfantil hemanjiom ve oral propranolol tedavisi

MUSTAFA DİLEK
MERVAN BEKDAŞ
Sevil GÖKSÜGÜR BİLİR
Fatih DEMİRCİOĞLU
Zehra KARATAŞ
Mustafa ERKOÇOĞLU
Erol KISMET
Pages
148–151
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This report presents a 3-month-old patient with infantile hemangioma in the right side of her face has been treated with oral propranolol therapy, accompanied by brief review of literature with treatment options.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infantile hemangioma is the most common bening tumors of infancy.
📊
Key Findings & Data:Common treatment indications include airway obstruction, ulceration, infection, visual impairment or feding difficulties.
💡
Conclusion & Impact:This report presents a 3-month-old patient with infantile hemangioma in the right side of her face has been treated with oral propranolol therapy, accompanied by brief review of literature with treatment options.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Infantile hemangioma is the most common bening tumors of infancy. Common treatment indications include airway obstruction, ulceration, infection, visual impairment or feding difficulties. Besides the steroids were the first choice in treatment of infantile hemangiomas for years, propranolol was also used in recent years.. This report presents a 3-month-old patient with infantile hemangioma in the right side of her face has been treated with oral propranolol therapy, accompanied by brief review of literature with treatment options.

Özet

İnfantil hemanjiom bebeklik döneminin en sık görülen selim tümörüdür. Tedavi endikasyonları arasın - da; havayolu tıkanıklıkları, ülserasyon, enfeksiyon, görme bozukluğu, emme bozukluğu gibi fonksiyon kayıplarına yol açması durumları sayılabilir. İnfantil hemanjiomun tedavisinde kortikosteroidler uzun yıllardır ilk tercih olmakla beraber son yıllarda oral propranolol de kullanılmaya başlanmıştır. Yüzün sağ tarafında geniş hemanjiomu bulunan 3 aylık hastada, propranolol tedavisi ile belirgin iyileşme sağlanmış ve güncel tedavi ile ilgili çalışmalar tartışılmıştır.

🔖

Cite This Article

DİLEK, M., BEKDAŞ, M., BİLİR, S. G., DEMİRCİOĞLU, F., KARATAŞ, Z., ERKOÇOĞLU, M., KISMET, E. (2015). Infantile hemangioma and oral propranolol therapy. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 49 - Sayı: 2, 148–151. https://ajindex.com/articles/364162

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Karaca İ, Türk E, Meşe T, Demirağ B. The use of propranolol as first-step treatment of infantile hemangioma: Case Presentation. Behcet Uz Cocuk Hast Derg 2014; 4: 65-8
  2. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer MC, Marchuk DA. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999; 82: 77-83
  3. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. The New England journal of medicine 2008; 359: 2846; author reply -7
  4. Chen TS, Eichenfield LF, Friedlander SF. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics 2013; 131: 99-108
  5. Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma. The British journal of dermatology 2013; 169: 12-9
  6. Torun YA, Ergül AB, Dursun İ. Propranolol infantil hemanjiomda birinci basamak tedavisi olarak kullanılabilir mi. Dicle Medical Journal 2011; 38: 95-7
  7. Bennett ML, Fleischer AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001; 137: 1208-13
  8. Leaute-Labreze C, Taieb A. Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Annales de dermatologie et de venereologie 2008; 135: 860-2
  9. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. The New England journal of medicine 2008; 358: 2649- 51
  10. Kozanoglu I, Yandim MK, Cincin ZB, Ozdogu H, Cakmakoglu B, Baran Y. New indication for therapeutic potential of an old well- known drug (propranolol) for multiple myeloma. Journal of cancer research and clinical oncology 2013; 139: 327-35
  11. Xu T, Xiao X, Zheng S, Zheng J, Zhu H, Ji Y, et al. Antiangiogenic effect of propranolol on the growth of the neuroblastoma xenografts in nude mice. Journal of pediatric surgery 2013; 48: 2460-5
  12. Bautch VL. VEGF-directed blood vessel patterning: from cells to organism. Cold Spring Harb Perspect Med 2012; 2: a006452
  13. Zhang L, Mai HM, Zheng J, Zheng JW, Wang YA, Qin ZP, et al. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell. International journal of clinical and experimental pathology 2014; 7: 48-55
  14. Ji Y, Chen S, Li K, Xiao X, Zheng S, Xu T. The role of beta- adrenergic receptor signaling in the proliferation of hemangioma- derived endotheli